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Genome wide association studies (GWAS) search for correlations between single 
nucleotide polymorphisms (SNPs) in a subject genome and an observed phenotype.  
GWAS can be used to generate models for predicting phenotype based on genotype, as 
well as aiding in identification of specific genes affecting the biological mechanism 
underlying the phenotype. 
In this investigation, phenotype prediction models are constructed from GWAS 
training data and are evaluated for performance on test data.  Three methods are used to 
rank SNPs by their correlation with the phenotype: the univariate Wald test, a 
multivariate, support vector machine (SVM) based technique, and a hybrid method where 
a subset of top ranked SNPs from the Wald test are used to train the SVM.  Both case-
control studies and quantitative phenotypes are examined.  For each method and data set, 
a series of least squares linear regression models is generated from nested subsets of the 
best SNPs from each ranking method.  The accuracy of these models is determined on a 
test data set, and a plot of prediction performance against the number of top ranked SNPs 
considered is generated. 
The SVM and hybrid methods are found to be consistently superior to the Wald 
test in ranking predictive SNPs.  The hybrid method allows a useful trade-off between 
increasing accuracy vs. using fewer SNPs to be optimized as desired. 
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Genome-wide association studies (GWAS) search the entire genetic profile of an 
organism for genetic variants, the result of mutation, that are correlated with phenotypes 
such as disease state.  Identification of such variants can be used to predict unmanifested 
phenotypes, such as likelihood of developing a disease, in subjects.  Knowledge of these 
variants can also shed light on the biological mechanisms underlying disease or other 
phenotypes.  The ability of GWAS to search over whole genomes can greatly accelerate 
the discovery of this useful knowledge, but this very power makes accurate analysis of 
GWAS data difficult.  Care must be taken to discern between useful results that reflect 
actual biological mechanisms and spurious findings caused by random correlations in the 
vast flood of raw data created. 
This investigation examines the use of statistical algorithms to find truly 
predictive SNPs in GWAS.  Three techniques are used to rank order SNPs by their 
significance to the phenotype: a univariate Wald test, which considers each SNP 
independently; a multivariate support vector machine (SVM), which considers all SNPs 
simultaneously; and a hybrid method which uses the Wald test to find a subset of best 
ranked SNPs which are then input to an SVM for final ranking.  These techniques are 
applied to several datasets, including quantitative phenotypes for levels of blood 
chemicals in mice, simulated case/control data, and case/control studies for different 
types of cancer.  Once a ranking of SNPs is generated, a series of least squares linear 





Predictive performance of these models is determined on a test data set and a plot of 
predictivity versus number of best ranked SNPs is created.  This procedure allows 
evaluation of the ability of each of the methods to discriminate truly predictive SNPs 
from false positives, without having to know beforehand which SNPs are actually 
significant. 
This thesis is organized as follows:  first a general description of GWAS is 
provided.  Then a description is given of the various statistical machine learning 
techniques used to find meaningful patterns in GWAS in order to identify significant 
SNPs and make predictions of unknown phenotypes from a genotype.  These techniques 
included least squares linear regression, the univariate Wald test for determining feature 
significance, the multivariate support vector machine technique for predictive modeling 
and feature selection, general machine learning techniques of model building and 
validation, and model selection by evaluating series of models generated from nested 
subsets of SNP features. 
After this basic introduction to concepts, the specific use of these techniques in 
this investigation is outlined in detail.  The data sets used are briefly described.  Finally, 





GENOME-WIDE ASSOCIATION STUDIES 
2.1 Genotypes and Phenotypes 
An organism's genotype is the set of all variants in the DNA code contained within each 
of the organism's cells.  Within a species, the vast majority of the DNA sequence is 
identical between individuals.  A particular location in this consensus sequence is known 
as a locus, so individuals in a species can be said to have identical genotypes at the 
majority of their loci.  However mutations create variants in this DNA sequence which 
can be inherited by offspring.  The combination of inherited DNA from both of an 
organism's parents, repeated over many generations, ultimately leads to each individual 
having a distinct, usually unique set of variants in its DNA sequence.  The different 
variants that exist in a population for a specific locus in a specie's DNA code are called 
the alleles of that locus [1,2]. 
Many kinds of genetic variants exist.  Segments of DNA within a chromosome 
can be inserted, deleted, replicated, moved to a different location in the same or in a 
different chromosome, or inverted in place.  One particularly simple and common type of 
variant is the single nucleotide polymorphism or SNP.  A SNP is created when a single 
nucleotide base in a DNA sequence is replaced with a different nucleotide base.  For 
example, an adenine "A" base at a specific location could be replaced with a thymine "T" 
base.  The nucleotide base variant most common in a population is called the major 
allele, while the less common base is the minor allele.  It is estimated that there are 10 





percent of the population.  Millions of these SNPs have been identified and published for 
the human genome [1-3]. 
For chromosomes other than the gender determining X and Y chromosomes, all 
humans have two copies of each genetic locus, one inherited from the mother and another 
from the father.  Therefore, the genotype of a person for a particular SNP can include 0, 
1, or 2 copies of the minor allele, corresponding to 2, 1, or 0 copies of the major allele 
respectively [1-3]. 
Recently developed DNA microarrays, also known as "gene chips," allow 
hundreds of thousands of SNPs to be reliably genotyped for an organism quickly and 
relatively inexpensively.  This has allowed studies to be done where thousands of 
subjects are typed for very many SNPs located throughout the entire range of the 
genome.  These genotypes can then be compared with observed phenotypes in the 
subjects in order to determine if any SNPs are statistically associated with the phenotype.  
These experiments are known as genome-wide association studies, or GWAS [1]. 
The phenotype for GWAS is most often simply the presence or absence of a 
specific disease state, for example presence or absence of a specific type of cancer, type 2 
diabetes, heart disease, or other condition.  The phenotype could also be whether a 
particular drug or medical treatment works or does not work for a patient.  These 
phenotypes are binary, representable by the two discrete values 1 or 0.  GWAS using 
such a phenotype include case/control studies.  It is also possible to use a continuously 
varying, quantitative phenotype for GWAS, such as the level of a chemical in the blood 
[4].  This investigation will analyze data from both kinds of studies: blood chemical 





presence or absence of disease is used as a binary phenotype in several case/control 
studies in humans. 
2.2 Linkage and Haplotypes 
A genetic variant which affects a phenotype, for example by increasing the level of a 
blood chemical or altering the odds of getting a disease, is called a casual variant.  Even 
though GWAS can genotype hundreds of thousands of SNPs, it is unlikely that any of 
these SNPs will be a causal variant.  The number, variety, and complexity of genetic 
variation exceeds the capability of GWAS to capture directly.  However, GWAS are still 
useful for associating genotypes with phenotypes because genetic variants are not 
distributed independently.  Genetic variants located near each other on a chromosome 
tend to be inherited together as a block through many generations.  This phenomenon is 
called genetic linkage, and a block of linked variants is called a haplotype.  Because the 
variants in a haplotype are highly correlated, genotyping just a few of the SNPs in a 
haplotype is sufficient to identify it uniquely.  This allows GWAS to discover 
associations between phenotypes and causal variants that they do not directly genotype.  
Variant alleles in those genotyped SNPs which lie in the same haplotype as a causal 
variant will share the statistical association with the disease phenotype in such studies 
[1,5]. 
Genetic linkage occurs because DNA is formed into chromosomes.  A single 
mutation will create a novel genetic variant on an individual chromosome that already 
has an inherited pattern of variants.  If such a chromosome was consistently reproduced 
as a single unit during meiosis, than all the distinct variants on the chromosome would 





generations of organisms.  The effect would be that the chromosome would form a single 
haplotype.  However, the phenomenon of chromosomal recombination, in which the two 
members of a pair of homologous chromosomes exchange corresponding lengths of 
DNA, tends to divide the linked variants into groups residing on distinct members of the 
homologous chromosome pair, after which they will be independently inherited.  The 
larger the number of base nucleotides lying between two variants, the higher the 
probability that recombination will occur between them and the genetic linkage between 
them will break.  Variants very close to each other, on the other hand, may stay linked for 
a large number of generations, so that a set of such variants will form a distinct haplotype 
which can be distributed throughout the entire population and endure for many 
generations [1,2,5]. 
2.3 SNP Association Models 
Given that a SNP can act as a statistical proxy for a causal variant in the same haplotype, 
a mathematical model for the association between the SNP and phenotype must be 
posited.  Recall that a subject organism can have 0, 1, or 2 copies of the minor allele for a 
given SNPs.  The simplest model, allele counting, assumes that the effect of the minor 
allele is directly proportional to the number of copies in an organism.  In effect, it assigns 
a value to the minor allele and assumes that the total effect of the SNP is this value 
multiplied by the minor allele count.  For binary phenotypes such as the absence or 
presence of disease, the value is interpreted as an odds ratio.  A baseline odds for getting 
the disease, applicable to a subject with no copies of the minor allele, is multiplied by this 
odds ratio: once for heterozygotes with one copy of the minor allele, and twice for 





contribution each copy of the minor allele will make to the numeric value of the 
phenotype [1,4,6,7]. 
This model makes the assumption that two copies of an allele have twice the 
effect of one copy.  The current investigation uses this model for the sake of simplicity, 
but it is important to note that more complex models are often more realistic.  In classical 
genetics, a dominant gene is one where a single copy of the causal allele has full effect, 
so that having two copies of the allele does not increase the effect.  A recessive gene is 
one where there is no effect unless both alleles are the minor allele.  Allele counting will 
not properly represent either of these common types of causal variant [2,7]. 
Another important assumption in all these models is that the effect of one causal 
variant is independent of the effect of a different variant.  In reality, different genetic 
variants often interact with each other in a non-linear fashion, so that the effect of one 
variant is highly dependent on the presence or absence of another variant.  Allowing 
"gene-gene interactions" into an association model makes it more realistic, but the 
statistical and computational complexity introduced thereby is considerable.  Therefore 
many GWAS analyses, including the current investigation, ignore such interactions [7]. 
2.4 Statistical Errors in GWAS 
Even with a simple allele counting model, correct identification  of  SNPs linked to 
causal variants is difficult because of standard types of statistical error.  Type II errors 
occur when the association between a SNP and a phenotype is real, but is not strong 
enough to pass a preset standard for statistical significance.  The null hypothesis -- that 
there is no association – is not rejected when it ideally should be, resulting in "false 





in loose linkage with a causal variant, type II errors can result.  They can be reduced by 
adding more subjects to the GWAS, but this raises the cost. 
Type I errors result when there is no true association between a SNP and a 
phenotype, but there appears to be one purely because of chance.  The random 
distribution of a SNP's alleles can correlate with phenotype even though no causal variant 
is involved.  This leads to rejection of the null hypothesis when it is actually a correct 
assessment, resulting in a "false positive."  GWAS are particularly prone to type I errors 
because of multiple testing.  The most useful feature of GWAS, the genotyping of many 
thousands of SNPs, multiplies the opportunity for type I errors.  If a p-value cutoff for 
rejecting the null hypothesis is set to 0.1%, which for many kinds of statistical studies is 
considered a very strict threshold, a GWAS will still produce tens or hundreds of false 
positives because so many SNPs are tested.  Only by setting a very low p-value threshold 
for rejecting the null hypothesis can the presence of type I errors be rendered unlikely -- 
but this inevitably increases the incidence of type II errors, screening out all but the most 
strongly associated SNPs.  These issues make correct interpretation of GWAS results 
difficult [1]. 
2.5 Uses of GWAS 
There are two possible aims for performing GWAS.  The most common aim is to identify 
locations in the genome that are associated with disease or other phenotype of interest to 
aid in biological discovery of the underlying genetic mechanisms.  Knowing that a 
genetic variant affecting a phenotype is found in a small region of a specific chromosome 
is of great benefit to further investigation to reveal the exact location, type, and effect of 





for medical investigation, or other desired information.  The abundance of type I errors in 
GWAS complicates the accurate determination of causal variants, but follow-up studies 
examining only the positive results of an initial GWAS can resolve these errors.  It is rare 
for a single GWAS to unambiguously find only SNPS truly associated with important 
casual variants, but it can find a set of tentatively associated SNPs for further 
investigation [1]. 
The other possible aim of GWAS is to create a predictive model that will allow 
prediction of hidden or undeveloped phenotypes from genotyping.  For example, if a 
certain genotype is often found in subjects who have already have a condition such as 
type II diabetes or heart disease, currently healthy individuals with similar genotype may 
have higher risk for developing this condition in the future.  Identification of such 
individuals can aid in assigning appropriate medical monitoring and preventative care to 
the persons who need it most.  Although predictive models are best generated only from 
SNPs linked to true causal variants, models with some degree of usefulness can still be 
generated from a set of GWAS positives without having to determine which positives are 
true and which are false [4].  The current examination takes advantage of this to compare 






FEATURE SELECTION AND PREDICTIVE MODELING 
 
SNP selection and phenotype prediction from GWAS data utilize techniques from the 
field known as machine learning.  A range of machine learning techniques exist, and 
determining which ones are most useful for GWAS data is a complicated problem in its 
own right.  The purpose of the current investigation is to compare the SNP selection 
performance of two common machine learning algorithms -- the univariate Wald test and 
the multivariate SVM -- on GWAS data, and to explore whether a hybrid method 
combining these algorithms can provide the best features of both. 
Since the causal SNPs in the GWAS data used are not known in advance (except 
for one simulated case/control data set), a least squares linear regression model is 
generated from the selected SNPs in a training data set, which is then used to predict the 
phenotype for a test data set that was not used during SNP selection and regression model 
building.  The measurable performance of the regression model on the test set is used as 
an indicator for the underlying performance of the SNP selection algorithm.  The least 
squares linear regression model is also the method underlying the univariate Wald test. 
3.1 Least Squares Linear Regression 
A predictive model generated for a GWAS will calculate the phenotype value as a 
function of the genotyped SNPs.  The simple allele counting model described above, 
which ignores gene-gene interactions and which considers the effect of each SNP to be 
proportional to the number of minor alleles, is linear.  This means that the output of a 




SNP values, where each SNP value is coded as 0, 1, or 2 for the number of minor alleles 
present at the SNP locus.  Linear regression is the process of generating such a linear 
function to model the relationship between certain variables in a data set. 
Linear regression tries to find a set of coefficients that best expresses an output 
value y, the dependent variable, as a linear function of one or more input values, the 
independent variables  through  .  This is expressed by the equation: 
 
nn xxxy   22110 (3.1)
 
or in vector notation 
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 are n-dimensional vectors. 
If the n-vector x

 is transformed into the vector of length n+1 by prepending a 1, 
this equation can be more simply written as 
 
βx




 is now also of length n+1, with a "0th" component representing 0  [8-10]. 
To fit a linear model for a set of GWAS data, assume there are m subject 
organisms with known phenotype and genotype at n SNPs.  The phenotypes can be 
represented as a vector y

 of length m, and the genotypes as an m  n+1 matrix X, where 





subject, and X[i,j] is the genotype for the jth SNP of the ith subject.  X[i,*] is the row 
vector representing the full genotype over all SNPs for the ith subject.  The task at hand is 
to find coefficients 0  through n  such that the predicted phenotype for the ith subject 
X[i,*]β

 -- written as ][ˆ iy  -- is closest to the actual observed y[i] for all i subjects.  If n < 
m there is no exact solution and a compromise solution must be generated that somehow 
minimizes the error [8-10]. 
The most common way to define the "best" β

 is by the least squares criterion.  
This is the line that minimizes the error defined as the sum over all squared residuals, 
where a residual is the difference between the observed phenotype y[i] for subject i and 
the predicted phenotype ][ˆ iy  = X[i,*]β

 calculated from the observed SNP genotypes for 
the subject X[i,*].  This sum is called the RSS for the residual sum of squares.  The 














To find the minimum RSS as a function of β






 and solve.  This results in what is known as the "normal equations", 
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provided that XXT  is nonsingular so that its inverse exists. 
It can be shown that the solution calculated by the least squares algorithm is the 
maximum likelihood estimator for β

 if the true  for each subject is accurately modeled 
by a linear function of the independent variables x

 for the subject plus a normally 
distributed error term with mean of zero and constant variance [8-10]. 
Determining a least squares model by solving the normal equations can give 
unstable results if some of the components of X -- the columns of the matrix X -- are 
highly correlated with each other.  In the extreme case where two components, say X[*,i] 
and X[*,j], are perfectly correlated with each other, the matrix XXT  becomes singular, 
its inverse does not exist, and the normal equations cannot be solved [10,11].  This case is 
important to discuss here because one of the genotyped data sets used in this investigation 
contains many SNPs that correlate perfectly with at least one other SNP in the data set, 
owing to a high degree of linkage disequilibrium between them. In addition to this 
concern, directly solving the normal equations is computationally inefficient.  Therefore 
other algorithms are usually used to fit a least squares linear regression model, which are 
faster, more stable, and capable of producing a solution even when XXT  is singular 
[10,11]. 
One common method uses QR decomposition.  This factors the X matrix into 
matrices Q and R, where Q is orthogonal and R is upper triangular [10,11].  This is the 
method used by the "lm" function in the widely used R statistical programming language.  





used to generate regression models in the early phases of the current investigation, but 
this ended up being unsatisfactory, owing to a subtle problem that is now described. 
As the QR factorization is being formed, columns in X which are linearly 
dependent can be detected and omitted from the model.  The ith column of X can be 
omitted simply by setting the ith component of β

 to zero.  Since no new information is 
contributed by a redundant column, the residual sum of squares for a model that omits it 
is not altered by the omission [10,11].  However this can lead to a problem when the 
regression model so formed is used for making predictions on a data set other than the 
one used to generate the model.  Two independent variables that are perfectly correlated 
in the initial training data set may not be so correlated in the new test data set.  In this 
instance, the model predictions for the test set will depend on which of the linearly 
dependent columns in the original data set was omitted.  In the lm function in R, columns 
are examined in order of increasing index, from "left-to-right" as the X matrix is factored.  
If a column is discovered that is identical to a column already considered, the new 
column is the one omitted.  This means that the model generated is dependent on the 
order that the SNPs are presented in the data set.  As the current investigation involves 
creating least squares regression models for sets of SNPs that have been differently rank 
ordered by the different algorithms being examined, this dependence on SNP order has a 
confounding effect on correctly comparing the algorithms' performance. 
Fortunately there is yet another means of generating a least squares linear 
regression model which is immune to this effect.  Performing a singular value 
decomposition, or SVD, factorization of the X matrix allows the computation of the 





solution to the least squares regression problem.  If the X is nonsingular the minimum 
norm solution is just the unique solution to the normal equations.  However if X is 
singular, there is no unique solution to the least squares problem [11].  This can be seen 
from the previous discussion of the QR least squares method, where the residual sum of 
squares could be minimized to the same value by omitting either one or the other of two 
identical columns in X, by setting the corresponding component of β

 to zero.  The 
minimum norm solution determined by SVD chooses a different solution.  It "splits the 
difference" and assigns an effect to both of the redundant columns that is exactly half of 
the effect that the QR method assigns to one and only one column.  This solution is 
unique for a given matrix X and is independent of the order of the columns in the X 
matrix [11].  For a GWAS model, this means that the SVD algorithm does not arbitrarily 
choose one of two redundant SNPs to be associated, but rather spreads the observed 
association evenly between both SNPs. 
The SVD algorithm is used by the scipy.linalg.lstsq function in the scipy scientific 
library extension for the python programming language.  This function was used to do 
linear regression for all final results in the current investigation, providing stable 
regression models free of column order dependency issues. 
3.2 Univariate Feature Ranking: the Wald Test 
Assessing the phenotype association of SNPs in a GWAS can be conducted either by 
univariate testing, which analyzes each SNP individually, or by multivariate testing, 
which simultaneously analyzes the association of a set of SNPs.  Univariate methods are 





For binary phenotypes and the simple allele counting model of SNP association, 
the "gold standard" statistical test is chi-square, based on the 2 x 2 contingency table for 
the two phenotypes and the two alleles.  For quantitative phenotypes it is necessary to 
perform a Wald test, which generates a least squares linear regression model using a 
single SNP for an independent variable and tests the significance of the model against the 
null hypothesis that there is no association between genotype and phenotype.  For a 
single SNP equation (1) reduces to 
 
xy 10    (3.7)
 
where  is the minor allele count for the SNP. 
The null hypothesis is expressed numerically by setting 1  to zero.  The 
distribution of 1  under the null hypothesis is a Student's t distribution, with n-2 degrees 
of freedom when the regression is performed on n data points.  The t statistic is the value 
of 1  calculated using the least squares algorithm divided by its standard error.  This 























The p-value for this t statistic can then be used in a test of statistical significance for the 
association between phenotype and the genotyped SNP [7,8,10]. 
In this investigation the Wald test is performed for all genotyped SNPs in a 





likely to be truly associated with phenotype and placed first and SNPs that appear not to 
be associated with phenotype are placed last.  Case/control studies are adapted to enable 
the use of the Wald test by setting the phenotype to be 1.0 for cases and -1.0 for controls, 
thus converting the binary phenotype to a quantitative one so that a least squares 
regression model may be fitted.  While it is rare to analyze case/control studies in this 
way, it is done here so that a single consistent technique is used for SNP ranking in all 
GWAS data sets considered in the current investigation, regardless of whether the 
original phenotype is quantitative or binary. 
3.3 Multivariate Feature Ranking: Support Vector Machines 
A popular multivariate machine learning technique is the support vector machine, or 
SVM.  SVMs are most commonly used for classification tasks, such as modeling 
case/control GWAS with binary phenotypes, but an SVM regression algorithm for 
modeling quantitative outcomes exists and is used in this investigation.  SVMs are 
flexible and powerful, and a large body of mathematical theory exists concerning them.  
The current discussion is limited to a brief overview of the SVM regression technique. 
Least squares linear regression, as stated previously, minimizes the RSS, the sum 
of squared residuals, where a residual is the difference between the predicted and actual 
values of the dependent variable.  In SVM regression this is replaced by the sum of error 
terms, with this term defined as 0 if the absolute value of the residual is below a threshold 
 , and as the absolute value of the residual minus   if the absolute value exceeds  .  
The contribution of the error is therefore a linear rather than a quadratic function of the 
residual, and there is a "grace zone" where the residual does not contribute to the error at 





The other prominent feature of the SVM method is that, in addition to minimizing 






.  This is interpreted as 
forming a simpler model, that ignores some of the variation in the training set data.  This 
trade-off between reducing error and reducing model complexity can ideally be used to 
create a regression model that captures the essential "signal" of the training set, such as 
the true association of phenotype to a SNP, while ignoring the random "noise" of false 
associations. 













must be minimized with respect to β

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where all i  and 

i are greater than or equal to 0 [9,10,12]. 
The i  and 

i  represent errors, where the model predicted ][ˆ iy  is different from 
the actual y[i] be more than  .  The first term in equation (9) is one-half the norm of the
β

 vector that defines the actual linear regression model, while the second term is the sum 
of the errors when using that β






predetermined and defines the relative weight for the trade-off between model simplicity 
and model error. 
A mathematical transformation allows this problem to be recast in what is called 
the dual form, which allows the solution for β

 to be defined in terms of a linear 
combination of a subset of the subject row vectors in X.  These row vectors are called 
"support vectors" because they "support" the solution, and hence the method determining 
and using them for regression modeling is the "support vector machine." [9,10,12] 
Once the β

 vector is determined, it can be used to rank features in order of 
importance.  This is done simply by ordering each feature by the absolute value of the 
corresponding coefficient in β

 in decreasing order.  This allows a SVM regression model 
to be used as a SNP selection method in GWAS. [13,14] 
Because SVM is a multivariate method, it has some advantages over a univariate 
method.  Unlike univariate methods, it can take into account redundancy between 
features.  This is similar to the fashion in which least squares linear regression will 
determine the coefficient i  for the ith feature in a training set in the context of all other 
features, producing a different coefficient than the least squares algorithm produces when 
only considering that single feature.  Another advantage of SVM, not shared by ordinary 
least squares regression, is that it attempts to simplify the model by minimizing the norm 
of β

, which can only be reasonably done by trading off the contributions of different 
features, an inherently multivariate process.[9,10,12] 
However SVM, like all multivariate methods, also has drawbacks. If the number 
of features equals or exceeds the number of subjects -- if X has as many or more columns 





generalization to new data.  In effect it fits the "noise" as well as the "signal" of the 
training data.  The minimization of β

 helps overcome this effect, but if the feature count 
is very large, it is difficult to find a truly optimum β

 amidst all the possible solutions.  
Computation cost also increases with feature count, and for GWAS with hundreds of 
thousands of SNP features it can be extremely difficult to find an SVM solution with 
limited time and computing resources. 
3.4 Model Bias, Variance, and Cross-Validation 
Predictive performance of least squares regression and SVM models, along with that of 
other machine learning techniques, can be examined in a more abstract sense. 
Machine learning methods analyze a set of data in order to discover a model 
which accurately reflects the process that created the data.  Most methods begin with an 
assumed general form for the model that includes a number of unspecified parameters.  
The specific model is then generated by analyzing the training data to determine 
estimates for the value of these parameters.  For example, least squares linear regression 
assumes that the dependent variable is determined by a linear function of the independent 
variables plus a random, normally distributed error.  The regression algorithm analyzes 
the training data to estimate a coefficient for each independent variable in this linear 
function -- these coefficients constitute the β

 vector that the algorithm generates.  Other 
machine learning techniques assume other kinds of underlying models and therefore 
estimate different parameters. 
When finding an optimum model, two contrary tendencies must be taken into 





actual underlying process which generates the data.  For example, if a dependent variable 
is actually determined by a non-linear function of the independent variables, then a linear 
model will not fully capture this relationship.  Similarly, if not all of the important 
independent variables are captured in the model, it will predict badly even if the 
underlying process really is linear.  This shortcoming is referred to as bias; the model is 
making simplifying assumptions about the underlying process which do not accurately 
reflect its true complexity.   To avoid bias, a more complex and flexible general model 
with more parameters can be chosen, so that the model is powerful enough to accurately 
represent the underlying process. 
On the other hand, a complex and flexible model with many parameters is more 
susceptible to capturing random associations in the data along with the true associations 
reflecting the underlying process.  Such a model can fit the original training data 
extremely well, but will badly predict any new test data.  It has learned to model the 
"noise" as well as "signal" in the training set, and so generalizes badly precisely because 
it captures the specifics of one particular set of data too well.  This shortcoming is called 
variance; the model is generating an overly complex model which does not best capture 
the truly significant patterns in the data. 
Finding a good model means finding an optimal trade-off between bias and 
variance.  This was mentioned previously in the context of the C parameter in equation 
(3.9) defining the SVM model.  A higher value of C emphasizes better fitting the training 
data at the expense of simplicity of the model.  This is decreasing the bias -- allowing the 
model to be more complicated -- but potentially increasing the variance by modeling the 





simplifying the model, but can decrease the variance as the simpler model is less 
susceptible to fitting random noise. 
Another factor in the bias vs. variance balance is the number of features used to 
build the model.  Adding more features to a model can decrease bias by giving the model 
more power to capture the actual process underlying the data, but it can also increase the 
variance by making the model too easily influenced by random associations.  The current 
investigation addresses this issue by creating a sequence of regression models based on 
an increasing number of SNP features, thereby examining a wide range of possibilities in 
the bias-variance trade-off. 
An important consequence of these concerns is that a model's performance should 
never be tested on the data set used to build the model.  In order to truly test how well a 
model generalizes beyond the data it is from which it is built, the model should be 
generated from a "training set" of data and then tested for performance against a 
completely separate "test set" of data, which is totally uninvolved in the model generation 
process.  In order to maximize the use of the available data, the full available data set is 
usually randomly divided to create the training and test sets.  This division, along with 
the subsequent model generation and testing procedure, is then repeated several times to 
get a robust estimate of performance. 
One popular technique for this, which is used in the current investigation, is cross-
validation.  The data set is divided into N equal parts.  All but one of these parts are 
combined into a training set that is used to generate the model.  The model's performance 
is then tested on the omitted part, which forms the test set.  This procedure is repeated N 





validation, each subject in the data has been predicted as part of a test set exactly once, 
and has been part of a training set N-1 times.  Each model is built using a fraction of 
N/(N-1) of the complete data set.  This whole process is called "N-fold" cross-validation.  
The current investigation uses 10-fold cross-validation for all data sets. [9,10] 
3.5 Model selection: Nested Subsets of Ranked Features 
Given that many different models, using different algorithms and feature sets, can be 
generated, choosing the best model can be a complicated process.  Even if only one 
general modeling technique is used, the number of possible sets of features that can be 
chosen increases exponentially with the number of features available.  For GWAS with 
many thousands of SNP features, it is computationally impossible to build models for all 
possible combinations of SNPs. 
Various strategies exist for searching the space of all possible feature sets for 
modeling.  For example, in forward selection a model is built and tested for each 
available feature in isolation, creating N univariate models for N available features.  The 
feature for the most predictive model is chosen.  Then N-1 models are built and tested, 
with each model being based on two features:  the feature selected from the previous step 
along with one of the N-1 remaining features.  From this round of testing, the additional 
feature associated with the best model is chosen and put in a "chosen set" with the first 
selected feature.  The process is then repeated using these two features in combination 
with each of the N-2 remaining features, allowing selection of a third chosen feature.  
This process is repeated, adding a new feature to the chosen set each time, until the model 
performance ceases to improve more than some predefined criterion.  The model based 





Backward selection is similar but works in the opposite direction.  A single initial 
model is built including all available features.  Then N models are built with all the 
features except for a single feature which is left out, and the omitted feature for the model 
that has the least decrease in performance is removed from consideration.  The process is 
iterated, removing one feature at a time, until the removal of any feature leads to an 
unacceptable decrease in model performance.  The model based on the set of features left 
at this point is selected as the optimum model. [9,10] 
An even simpler method is used in the current investigation, which is not seeking 
the best possible model, but instead using models to compare feature ranking techniques.  
The feature ranker, a machine learning algorithm of some sort, is used to assign a 
statistical significance value to each of the N features.  The features are then placed in a 
list rank ordered by decreasing significance.  Then a set of N models are built, with each 
model including the i best ranked features where i ranges from 1 to N.  This forms a 
sequence of models built on nested subsets of features.  Each model contains all the 
features of the previous model plus one additional feature, the next one in rank order.  
This technique is simple to understand and computationally feasible even for many 
features, but its success depends on the ability of the ordering algorithm to correctly rank 
features by their significance. [13] 
A particular caution must be taken with feature selection.  Many models are built 
on a training set and then used to predict a test set.  The model with the best predictive 
performance is then chosen.  However this process is actually a form of training, because 
choosing which of the many possible feature sets generates the best model is a form of 





becomes a kind of adjunct training set, violating the prohibition that models should not be 
trained on test data.  In order to determine the true performance of the selected feature 
set, the model generated from it must be used to predict another, completely novel test set 
of data that was not involved in the feature selection process.  In the current investigation, 
this final step is not taken, so no conclusions about the absolute performance of the best 
model can be drawn.  However the relative performance of the models generated, 
especially when examined as a trend rather than a single result, can still provide insight 
into the best strategies for feature selection.  The current investigation takes advantage of 





METHODS AND DATA 
4.1 Purpose of the Investigation 
The current investigation explores the relative performance of three kinds of feature 
ranking methods: the univariate Wald test ranking of all SNPs, the multivariate SVM 
regression ranking of all SNPs, and a hybrid method in which a number of the best 
ranked SNPs from the Wald test are used as training input to the SVM, which then 
produces a ranking of just this subset of SNPs.  The interesting hypothesis examined is 
that the hybrid technique of using a univariate method to filter a subset of SNPs, which 
are then ranked by a multivariate method, may capture the best properties of both 
methods. [14]  The univariate filter allows very large numbers of SNPs to be ranked with 
reasonable computational resources, and since each SNP is analyzed independently, the 
test for association cannot be degraded by trying to process too many features at once.  
Then the best results of this filter are passed to a multivariate method, which can 
accommodate redundancy between SNPs and can also properly balance the bias vs. 
variance trade-off to generate a superior ranking of this subset of SNPs.  Because the 
multivariate method only sees a limited number of filtered SNPs, it is computed faster, 
and is less likely to be overwhelmed by too many features, compared to SVM run on all 
genotyped SNPs. 
4.2 Data Sets 
Several different data sets are used in this investigation.  They are briefly described here 





for all case/control studies, a phenotype of 1.0 is assigned to cases and -1.0 is assigned to 
controls, so that they can be treated as quantitative phenotypes by the univariate Wald 
test and multivariate least squares regression models.  All data sets, except for one 
simulated set, are taken from publicly available GWAS data. 
One master data set is taken from a study genotyping a heterogeneous stock of 
laboratory mice, which were bred by mixing 8 inbred strains to increase genetic diversity.  
In addition to genotyping, multiple quantitative phenotypes were measured.  This 
investigation uses two of these phenotypes: mean cellular hemoglobin (MCH), a 
measurement of hemoglobin content in red blood cells, and percentage of CD8 cells 
(CD8), the relative proportion of a type of immune system lymphocyte. [4] 
A simulated case/control data set is generated used the freely available 
GWASimulator software.  A set of 15 "causal SNPs" are each assigned an odds ratio of 
2.0 per minor allele for increasing the base risk of disease case status. Using these 
parameters, 1000 case subjects and 1000 control subjects are generated, using the defined 
odds ratios for causal SNPs to generate these subjects' genotypes according to the 
corresponding disease risk probability distribution.  For each causal SNP except one, 
2000 non-causal SNPs are simulated, with the causal SNP in the precise middle of a run 
of consecutive SNPs.  The remaining SNP is near the end of a chromosome, so only 1187 
non-causal SNPs are simulated around it. 
GWASimulator simulates the linkage in each run of consecutive SNPs according 
to a chromosomal profile based on the International HapMap Project findings.  This 
produces simulated GWAS data with realistic SNP linkage characteristics.  Unlike most 





disease status are precisely known.  This allows SNP selection methods to be evaluated 
directly, as well as indirectly via phenotype prediction performance. [15] 
Three case/control data sets are taken from GWAS conducted on humans, with 
different types of cancer as the phenotype which is present or absent.  The disease types 
are breast cancer [16], pancreatic cancer [17], and prostate cancer [18].  These data sets 
are genotyped for many more SNPs than the mouse and simulated data sets, preventing 
the use of SVM with all of the SNPs as input features owing to computational constraints. 
 
Table 4.1 Subject and SNP Counts for Data Sets 
Data Set # of Subjects # of SNPS (pre-filtering) 
Mouse 1591 12545 
Mouse CD8 1521 12545 
Simulated 2000 28498 
Breast Cancer 2287 513363 
Pancreatic Cancer 3937 538099 
Prostate Cancer 2300 317503 
 
Certain data clean-up and formatting operations are initially applied to all data 
sets.  The plink software package [6,7], specifically designed for managing and analyzing 
GWAS data, is used.  Initially, the data set is filtered.  SNPs with missing data in more 
than 1% of subjects are omitted.  SNPs with the same genotype for all subjects are also 
excluded as no association with phenotype can be determined in this case. 
Next, the data is analyzed to determine the counts of each genotype (0, 1, or 2 





replaced with the most frequently occurring genotype, a very simple kind of data 
imputation.  This step, along with the initial exclusion of SNPs with a more than one 
percent missing data, generates a data set where all genotypes are defined for all subjects 
with minimal perturbation of the original statistical structure of the data. 
Finally, now that the data set is properly filtered and adjusted, it is output in two 
alternate formats: a binary format specific to plink, which increases performance for 
Wald testing, and a text format where the genotypes are numerically encoded by the 
number of minor alleles so that the SVM and linear regression software packages can 
model them. 
4.3 Analysis Procedure 
All data sets are modeled and tested using 10-fold cross-validation.  SNP ranking and 
least squares regression model building are conducted using only the training set, creating 
a panel of different regression models for each ranking method and SNP count.  All 
prediction performance testing for these models is done using only the test set.  In this 
way each subject in the data set is predicted once by each type of generated model, with 
the models built from a training set comprising 90% of the subjects in the data set but not 
including the subject being predicted. 
For each training set a group of SNP rank orderings are generated.  First the 
univariate Wald test is run for all SNPs, and a "WALD_ALL" ranking is generated where 
SNPS are ordered by increasing p-value -- which is by decreasing statistical significance 
of association with the phenotype -- as determined by the Wald test.  For the mouse and 
simulated case/control datasets, an SVM ranking is then generated for all SNPS, 





SNPs for an SVM_ALL ranking to be generated, so this ranking is omitted for these 
datasets. 
Next a set of hybrid Wald-SVM rankings is generated.  For the mouse and 
simulated case/control data sets, the number of Wald ranked SNPS input to the SVM is 
determined by the number of SNPs with a Bonferroni-corrected p-value less than 0.05, a 
quantity called "R" in this investigation.  (Note that "R" for the number of SNPs passing 
this p-value filter is not to be confused with "r" for the Pearson's correlation coefficient, 
which is determined by comparing predicted and actual phenotype values.)  A p-value 
output by the Wald test is Bonferroni-corrected by division by the total number of ranked 
SNPs, which compensates for the increased probability of type I errors caused by 
multiple testing.  This means that there is only a 5% chance that any of the SNPs in the  R 
top ranked SNPs are falsely associated with the phenotype. 
The hybrid Wald-SVM rankings are generated by only using the best ranked N x 
R SNPs as input to the SVM training set, where N is a small integer.  SVM rankings are 
generated based on the best 2 x R, 5 x R, and 10 x R ranked SNPs from the WALD_ALL 
ranking.  This generates the rankings denoted as SVM_02R, SVM_05R, and SVM_10R. 
For the cancer case/control datasets, there are frequently no SNPs with 
Bonferroni-corrected p-value under the 0.05 cutoff, so that R is zero.  Therefore a pre-
determined number of best SNPs from the WALD_ALL ranking is input to the SVM.  In 
this way SVM rankings are generated for the best 5, 10, 50, 100, 500, 1000, 5000, and 
10000 Wald ranked SNPs. 
Once all the rankings are generated, a sequence of least squares linear regression 





ranking, where n is set in turn to each integer from 1 up to N.  Here N is the maximum of 
the total number of SNPs in the ranking or 1000.  Each model therefore includes all the 
SNPs used in models previous to it in the sequence, plus the next SNP in order from the 
ranking.  For each of these models, all subjects in the test set are predicted, and the 
Pearson's correlation coefficient r is calculated for the correlation between predicted and 
actual phenotype values of the test set.  The value of r for each SNP count is saved. 
The average of the correlation r for each SNP count, for each ranking method, is 
calculated over all ten cross-validation runs and plotted.  Statistics for the mean, standard 
deviation, maximum, and minimum over all ten cross-validation runs are calculated for 





5.1 Mouse Data 
The mouse data sets provide the best test bed for this investigation.  The phenotypes are 
truly quantitative, not just "quantified" case/control studies, so the linear regression and 
SVM methods are highly appropriate to model them.  The heritability of MCH is 
estimated at 0.55 and that of CD8 at 0.99 [4], which means there is a significant genetic 
component to these traits.  The plots reveal the trends of the various ranking methods 
quite clearly. 
 
Figure 5.1  Plot of Pearson's correlation coefficient for predictions on mouse MCH data 





In Figure 5.1 it can be seen that the Wald ranking performance is substantially 
worse than any of the SVM ranking.  SVM_02R is somewhat better, SVM_05R better 
than that, and SVM_10R and SVM_ALL are about evenly the best overall.  Also of note 
is the rate of prediction performance increase as the SNP count increases.  For the first 
few SNPs, all rankings gain predictivity very quickly; presumably this represents a few 
highly significant SNPs that are easily found and best ranked by all methods.  After that, 
the Wald ranking "levels off" and only slowly increases performance as more SNPs are 
added.  All the SVM methods, on the other hand, continue to gain predictivity quickly 
until eventually reaching a maximum.  Since a primary purpose of GWAS is to identify a 
small set of SNPs for further investigation, in order to aid in the discovery of underlying 
biological mechanisms, this ability of the SVM methods to place a relatively small set of 






Figure 5.2  Plot of Pearson's correlation coefficient for predictions on mouse CD8 data as 
a function of number of best ranked SNPs included in the regression model. 
 
In Figure 5.2 the SVM_10R and SVM_ALL ranks are missing.  This is because 
the "R" value is very high, so much so that SVM_05R is in fact SVM_ALL: fewer than 5 
x R SNPs are genotyped.  Therefore SVM_10R and SVM_ALL would be redundant with 
SVM_05R.  The signal is quite strong, with very many contributing SNPs.  Similarly to 
MCH, we see that the SVM rankings perform better than the Wald ranking.  However the 
difference is not as significant as for MCH.  Also, the rapid "early rise" of the predictivity 
curve is not as strongly differentiated between Wald and SVM rankings as for MCH.  It 






5.2 Simulated Data 
The simulated data set demonstrates what happens when a particularly strong signal is 
contributed by a relatively small number of SNPs. 
 
Figure 5.3  Plot of Pearson's correlation coefficient for predictions on simulated 
case/control data as a function of number of best ranked SNPs included in the regression 
model. 
 
All rankings very quickly find all "causal SNPs" as well as neighboring SNPs that 
are strongly linked to the causal SNPs.  The Wald test very slightly outperforms the SVM 
methods, but not significantly.  The SVM methods are so similar that it is difficult to 
discriminate them in the plot.  The SVM_02R curve is plotted, but is basically 
overwritten by the other SVM curves and is thus invisible.  The SVM_05R and 





It should be noted that the underlying data process in this data set is in perfect 
accord with the model assumptions that the machine learning techniques implicitly apply.  
There are no interactions between SNPs, and the effect of each SNP is perfectly modeled 
as an odds ratio multiplied by the number of minor alleles.  This fact, combined with the 
small number of causal SNPs and the relatively high odds ratio for each one, makes this 
data set very easy to correctly analyze for all techniques.  Inspection of the actual SNPs 
rankings reveals that all highly ranked SNPs are indeed causal or near neighbors of causal 
SNPs – a finding that can only be made for a simulated data set where the true underlying 
process is known ahead of time. 
5.3 Cancer Data 
The three cancer data sets genotype far more SNPs, and include more subjects, than the 
mouse data.  However the genetic signal is very small.  The initial GWAS that collected 
this data identified a few significant SNPs, but could only confirm them using additional 
data sets from other studies.  The results of the current investigation with these data sets 
are on the edge of significance. 
Because the R values for these data sets are almost always zero, it is not plausible 
to use multiples of R as SNP counts for creating SNP subsets for the SVM methods.  An 
alternate method  is used where fixed number of best ranked SNPs from the Wald test are 
used to train the SVM models.  The results are displayed in two plots for each data set: 
one plot for the smaller SNP counts of 5, 10, 50, and 100, and another plot for the larger 
SNP counts of 500, 1,000, 5,000, and 10,000.  The Wald test ranking results of displayed 





these studies was too large to be processed by the SVM with available computing 
resources. 
 
Figure 5.4  Plot of Pearson's correlation coefficient for predictions on breast cancer 
case/control data as a function of number of best ranked SNPs included in the regression 






Figure 5.5  Plot of Pearson's correlation coefficient for predictions on breast cancer 
case/control data as a function of number of best ranked SNPs included in the regression 
model, for large numbers of SVM ranked SNPs and Wald ranked SNPs. 
 
For the breast cancer data set, all ranking methods have essentially no predictive 
power.  While looking at the plots may create the illusion that the SVM methods predict 
better for large numbers of input SNPs, the statistical variation between individual cross-






Figure 5.6  Plot of Pearson's correlation coefficient for predictions on pancreatic cancer 
case/control data as a function of number of best ranked SNPs included in the regression 







Figure 5.7  Plot of Pearson's correlation coefficient for predictions on pancreatic cancer 
case/control data as a function of number of best ranked SNPs included in the regression 
model, for large numbers of SVM ranked SNPs and Wald ranked SNPs. 
 
For pancreatic cancer the predictivity is still very small, but a bit of a trend can be 
discerned.  There is a small predictive power in the first ten or twenty best ranked SNPs 
from the Wald test.  SVM offers no benefit when applied using these few SNPs.  After 
this initial signal, predictivity decreases towards zero as more SNPs are added, confusing 
the initial "signal" with "noise."  However when the SNP counts increase, additional 
signal starts to appear again, as if a large quantity of SNPs each with very small 
contribution to disease are acting in concert.  Both Wald and SVM rankings with many 





increases.  When five or ten thousand SNPs are input to the SVM ranking, it appears to 
provide a small advantage over the Wald test. 
 
Figure 5.8  Plot of Pearson's correlation coefficient for predictions on prostate cancer 
case/control data as a function of number of best ranked SNPs included in the regression 







Figure 5.9  Plot of Pearson's correlation coefficient for predictions on prostate cancer 
case/control data as a function of number of best ranked SNPs included in the regression 
model, for large numbers of SVM ranked SNPs and Wald ranked SNPs. 
 
The prostate cancer data provides the strongest signal of any of the cancer data, 
although one that is still very small.  In this case the Wald test has the best overall 
performance, with all of the SVM rankings appearing to diminish predictivity overall.  
However for small numbers of SNPs -- from about 50 to 1,000 SNPs as input to SVM -- 
the SVM rankings initially perform better than the Wald ranking, so for identification of 







This investigation shows that multivariate SVM ranking can definitely improve on 
univariate Wald ranking in many circumstances.  However, this is not universally true, as 
some data sets and ranges of SNPs under consideration are better predicted with the Wald 
ranking.  The behavior of different data sets varies widely, reflecting the complexity of 
the genetic architecture influencing phenotypes.  The simulated data produces clear, 
easily comprehensible results, and all ranking methods were essentially equal in 
discovering the statistical patterns in the data set.  The data from actual GWAS is much 
more problematic.  The best ranking algorithm varies almost on a case by case basis. 
Often a trade-off must be made between achieving the maximum possible overall 
predictivity of phenotype and identifying a small number of SNPs with the most effect.  
The most common use of GWAS is for the latter purpose, so methods that rank a few 
good SNPs highly should receive attention even if their overall predictivity is less than 
optimal.  This investigation unfortunately cannot offer a definite prescription for 
achieving the desired end in GWAS, but it does show that multivariate methods such as 
SVM are well worth trying.  The hybrid method using a univariate filter with a 
multivariate ranking can sometimes provide advantage in the identification of a few most 
significant SNPs, but the filtering does not seem to improve overall predictivity 
compared to running SVM on all available SNPs.  However when the GWAS genotypes 
a very large number of SNPs this is computationally infeasible, so using a univariate 





In addition to examining the ranking methods themselves, this investigation 
provides insight into issues with least squares linear regression applied to SNPs with a 
high degree of linkage.  The issues arising from different algorithms used to form a least 
squares model when some independent variables are perfectly correlated are subtle.  
Much time was expended in this investigation discovering, understanding, and resolving 
this phenomenon.  Many discussions of least squares regression in the literature do not 
examine these issues in depth, because most statistical data sets are set up to only use 
independent variables that are very unlikely to be perfectly correlated.  GWAS are an 
exceptional case where a very large quantity of SNP features, each being described by 
one of a few discrete values (0, 1, or 2 minor allele count), can have high correlation due 
to linkage.  The inability of the very popular statistical programming language R to 
adequately handle this issue in its default least squares functionality proves that GWAS 
investigators need to be especially aware of limitations and assumptions of the software 
they choose, as the data sets they examine have distinctive properties not found in many 
other statistical investigations. 
6.2 Future Directions 
As in all research projects, very many interesting avenues of investigation could not be 
pursued in the time available for the current investigation.  Far more research is called for 
to provide truly meaningless assessment of univariate and multivariate machine learning 
tools applied to GWAS data.  Some possibilities for additional research are suggested 
here. 
It is standard when applying SVM methods to try several different values of the C 





variance. [9,10,12]  Time did not allow for this basic procedure to be applied in the 
current investigation.  Instead, a single C factor is chosen that allowed the SVM to 
complete in a reasonable amount of time, using the default value set by the SVM light 
software as a rough guide.  The cancer data sets require a different value of C than the 
mouse and simulated data sets in order for the SVM model to finish in reasonable time, 
but no meaningless investigation of the appropriate value for this parameter is performed.  
Further investigation of the effect of different values of C is recommended. 
SVM in the current investigation is only used for ranking, with all actual 
prediction carried out by the least squares linear regression technique.  SVM is primarily 
known as a predictive modeling method, not a feature ranker, so comparison of actual 
predictions from SVM models to the least squares results would be of interest. 
The Wald test and linear regression are techniques designed for quantitative 
outcomes which vary continuously.  Their application to case/control studies with binary 
outcomes certainly works well, but other techniques are generally preferred for modeling 
such data.  Logistic regression is a technique related to linear regression but modified to 
produce probabilities for binary outcomes. [9,10] 
In addition to SVM, many other multivariate machine learning techniques are 
available which provide control over the trade-off of bias vs. variance.  Techniques of 
regularized regression augment the least squares linear or logistic regression algorithms 
with penalties on model complexity that can be adjusted.  Examples include ridge 
regression, lasso, and elastic net techniques.  Lasso in particular is optimized for 
identifying a small subset of highly predictive features. [10]  SNP ranking using some of 





The current investigation must be brought to a close, but hopefully the software 
and methods developed for it, and its ambiguous but intriguing findings, can provide a 






GWAS are a major innovation in the study of genetic causes of disease and other 
phenotypes, but the very power of this data collection technique makes accurate analysis 
of the data difficult.  Innovation in genotyping methods continues at an extremely rapid 
pace, and already it is expected that complete sequencing of subject genomes will soon 
replace SNP-based techniques in many studies.  In this event issues such as less than 
perfect linkage between causal variants and SNPs, and the effect of rare variants not 
detected by a panel of SNPs identifying standard haplotypes, will cease to be a concern. 
Causal variants of any type or frequency will be directly genotyped, with no need for 
SNPs to act as statistical proxies for the true biological associations.  However this vast 
increase in detailed genetic data will not obviate the essential statistical issues involved in 
associating genotype and phenotype, but rather magnify them in proportion to the 
increase in raw data available. 
Therefore, even if traditional SNP-based GWAS are on their way to becoming 
obsolete, the data analysis issues examined in the current investigation will not follow 
them into history.  Assessment of the range of machine learning techniques and their 
application to the particularly complex field of genetic studies will only increase in 
importance.  It is hoped that the current investigation will be a very small contribution 
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